GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NuGen Medical Devices Inc (TSXV:NGMD) » Definitions » EV-to-FCF

NuGen Medical Devices (TSXV:NGMD) EV-to-FCF : -8.96 (As of Jun. 02, 2024)


View and export this data going back to 2021. Start your Free Trial

What is NuGen Medical Devices EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, NuGen Medical Devices's Enterprise Value is C$29.06 Mil. NuGen Medical Devices's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was C$-3.25 Mil. Therefore, NuGen Medical Devices's EV-to-FCF for today is -8.96.

The historical rank and industry rank for NuGen Medical Devices's EV-to-FCF or its related term are showing as below:

TSXV:NGMD' s EV-to-FCF Range Over the Past 10 Years
Min: -22.01   Med: -8.04   Max: -2.11
Current: -8.96

During the past 4 years, the highest EV-to-FCF of NuGen Medical Devices was -2.11. The lowest was -22.01. And the median was -8.04.

TSXV:NGMD's EV-to-FCF is ranked worse than
100% of 360 companies
in the Medical Devices & Instruments industry
Industry Median: 27.295 vs TSXV:NGMD: -8.96

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-02), NuGen Medical Devices's stock price is C$0.10. NuGen Medical Devices's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.037. Therefore, NuGen Medical Devices's PE Ratio for today is At Loss.


NuGen Medical Devices EV-to-FCF Historical Data

The historical data trend for NuGen Medical Devices's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuGen Medical Devices EV-to-FCF Chart

NuGen Medical Devices Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- -7.32 -5.22 -4.66

NuGen Medical Devices Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.56 -5.22 -11.59 -15.68 -4.66

Competitive Comparison of NuGen Medical Devices's EV-to-FCF

For the Medical Devices subindustry, NuGen Medical Devices's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NuGen Medical Devices's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NuGen Medical Devices's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where NuGen Medical Devices's EV-to-FCF falls into.



NuGen Medical Devices EV-to-FCF Calculation

NuGen Medical Devices's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=29.063/-3.245
=-8.96

NuGen Medical Devices's current Enterprise Value is C$29.06 Mil.
NuGen Medical Devices's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-3.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NuGen Medical Devices  (TSXV:NGMD) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

NuGen Medical Devices's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.10/-0.037
=At Loss

NuGen Medical Devices's share price for today is C$0.10.
NuGen Medical Devices's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.037.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


NuGen Medical Devices EV-to-FCF Related Terms

Thank you for viewing the detailed overview of NuGen Medical Devices's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


NuGen Medical Devices (TSXV:NGMD) Business Description

Traded in Other Exchanges
Address
18 King Street East, Suite 1400, Toronto, ON, CAN, M5C 1C4
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needless injector devices. Geographically the company generates revenue from Asia, Europe and others.
Executives
Richard Buzbuzian Director, Senior Officer

NuGen Medical Devices (TSXV:NGMD) Headlines

No Headlines